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but not its interpatient reproducibility (2). In contrast, it is well-
nown that CFR is extremely variable in different patients, being
nfluenced, among the other things, by risk factors and age (3,4).
Second, the value of FFR is influenced not only by stenosis
everity, but also by the amount of viable myocardium subtended by
he epicardial coronary branch harboring the stenosis (5). This implies
hat a stenosis localized on the proximal left anterior descending
oronary artery would have a completely different functional signifi-
ance, and thus a different FFR, compared with an identical lesion on
second obtuse marginal branch. Similarly, the same stenosis would
e associated with a different FFR value in the presence of viable or
carred myocardium (5). Of note, in the paper by Koo et al. (1), 17%
f patients had a history of myocardial infarction.
Third, the incremental diagnostic yield of FFR is related to the
valuation of intermediate coronary stenoses (i.e., those usually
anging from 50% to 70% on visual angiographic assessment). In
he paper by Koo et al. (1), less than one of third of all lesions were
ithin this range on coronary computed tomography angiography
valuation. In the subset of coronary intermediate stenoses, al-
hough the overall accuracy of FFRCT was still acceptable (83%),
the sensitivity and positive predictive value were quite low (66.7%
for both). This challenges the clinical value of FFRCT in the
ssessment of those lesions for which clear proof of functional
ignificance is indeed needed.
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Reply
We thank Dr. De Caterina and colleagues for their interest in our
study, which demonstrates a high diagnostic performance of a
noninvasive method for computing fractional flow reserve (FFR)
from coronary computed tomography angiograms (FFRCT) (1).FRCT is calculated by computational simulation of adenosine-
mediated hyperemia rather than by actual administration of
adenosine. This allows FFRCT to determine coronary flow and
ressure without additional medications or image acquisition.
alculation of FFRCT is enabled by a predictable response of
denosine to reduce microcirculatory resistance downstream of
picardial coronary arteries. As discussed in our paper, the micro-
irculation reacts predictably to maximal hyperemia in patients
ith normal coronary flow, which reflects the fact that the maximal
otential change in peripheral resistance from baseline to hyper-
emic conditions is preserved for microcirculatory vascular beds. In
patients without coronary artery disease, the change in epicardial
resistance is small between rest and hyperemia and allows the
establishment of the limits of maximal change in microcirculatory
resistance achievable in patients with microcirculatory dysfunction.
Notably, this concept underscores the very definition of FFR,
which also assumes that hyperemic microcirculatory resistance
distal to a stenosis is identical to the resistance in the hypothetical
case that the coronary arteries have no stenosis.
We agree with Dr. De Caterina and colleagues that coronary
flow reserve (CFR) demonstrates variability for different patients.
CFR is a different metric from FFR, given its dependence on all
factors that affect blood supply to the microcirculation, including
aortic pressure, epicardial resistance, and microcirculatory resis-
tance. In this regard, CFR may be abnormal even as the response
of the microcirculation to adenosine remains normal.
We agree that FFR is influenced by “the amount of viable
myocardium subtended by the epicardial coronary branch harbor-
ing the stenosis.” This input condition is meticulously factored into
all FFRCT models by setting the resistance of a coronary artery
istal to a stenosis to be inversely (but not linearly) related to the
ize of the distal vessel. As blood vessels adapt proportionally to
ow, a vessel feeding a dysfunctional territory will decrease in
aliber and result in increased resistance in FFRCT models. This
adaptive process is time dependent, and, thus, patients with recent
myocardial infarctions were excluded from our study.
We disagree with the claim of Dr. De Caterina and colleagues
that the utility of FFR is limited to lesions of intermediate stenosis.
Angiographic stenosis is a highly unreliable surrogate for ischemia,
in which a significant proportion of anatomically high-grade
lesions do not cause ischemia. Application of FFRCT to these
lesions may be invaluable for avoiding unnecessary invasive proce-
dures provoked by physiologically irrelevant lesions. Conversely,
even for anatomically mild lesions, a non-negligible rate of
ischemia is consistently noted. Application of FFRCT to these
esions may identify patients whose lesions fall below an anatomic
hreshold of “severe” but who experience ischemic symptoms. In
his regard, FFRCT should be considered an invaluable adjunct to
oronary computed tomography angiography for lesions in all
tenosis categories.
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Fractional Flow
Reserve Estimation
by Coronary Computed
Tomography Angiography
We read with great interest the paper about the DISCOVER-
FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via
Noninvasive Fractional Flow Reserve) study, which compared frac-
tional flow reserve (FFR) derived from coronary computed tomogra-
phy angiography (CTA) with invasive FFR measurements (1). CTA
is a reliable test to rule out coronary artery disease based on its high
sensitivity and negative predictive value compared with conventional
angiography as the reference (2). Considering the importance of
nvasive FFR as part of conventional coronary angiography for
ubsequent revascularization decisions (3), it would be game-changing
f a reliable estimation of FFR could be performed noninvasively (4).
The DISCOVER-FLOW study is an important step in this
irection. We would like to discuss 2 issues related to the study
esign and statistics.
1. Patients with an at least 50% diameter stenosis determined by
he clinical site on CTA were studied using invasive FFR, which
erved as the reference in the study, but was done as clinically
ndicated. Thus, the final cohort of vessels that had invasive FFR
easurements represents a subgroup that may be biased by the
ocal CTA reading and a higher prevalence. This results in an
verestimation of sensitivity and an underestimation of specificity.
his can be seen from a different version of the Bayes formula
eeded to calculate sensitivity from predictive values: sensitivity 
PV · T/(PPV · T (1NPV) · T), where T and T are the
proportion of test positives and negatives in the study sample and
PPV and NPV are the positive and negative predictive values.
The proportion of test negatives, T is underestimated, if T is
calculated in the sample of verified subjects or vessels only. A very
conservative estimate is to assume 3 vessels per person (i.e., 309
vessels overall). According to Koo et al. (1) 114 vessels were positive
(53 true positive, 61 false positive) on CTA. Thus, we assume 195
negative vessels by CTA from which only 45 were assessed by the
reference standard FFR. If we further assume that the observed
Corrected Diagnostic Performance CharacteristicsTable 1 Corrected Diagnostic Performance Characteristics
Listed Diagnostic
Performance of CTA (1)
Corrected Diagnostic
Performance of CTA
Sensitivity, % 91.4 71.0
Specificity, % 39.6 74.0
Negative predictive
value, %
88.9 97.4CTA  computed tomography angiography.negative predictive value is the true one, we can obtain corrected
diagnostic performance estimates (Table 1). It is likely that the same
holds true for computed tomography FFR. However, it is difficult
to assess this without the correlation structure of both index tests
within truly diseased and truly unaffected vessels. If both tests are
conditionally independent (i.e., independent within the true pos-
itives and the true negatives), the naive estimates of sensitivity and
specificity are unbiased.
2. The limits of agreement between FFR and computed
tomography FFR resulting from a regression of absolute differences
according to Altman (5) suggest that these are not constant but
increase linearly with smaller FFR results (r2 linear model 0.335,
r2 quadratic model  0.340, r2 cubic model  0.340) (Fig. 1). In
ther words, the more positive (lower) the FFR results become, the
arger are the limits of agreement (95% confidence intervals).
These additions may be important when appraising the impres-
ive DISCOVER-FLOW study results.
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Figure 1 Bland-Altman Analysis of FFR and CT-FFR
The difference between the upper and lower limits of agreement for the com-
parison of fractional flow reserve (FFR) and computed tomography fractional
flow reserve (CT-FFR) are not constant but increase linearly with smaller FFR
results (5). Thus, the agreement between FFR and CT-FFR becomes less accu-
rate with positive (0.8) measurements.doi:10.1016/j.jacc.2011.12.031
